FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to veterinary science and medicine, and may be used to prevent and treat bacterial infections. An antibacterial injectable pharmaceutical composition comprises azithromycin, solvents and/or co-solvents, a preserving agent, and an antioxidant. The antioxidant is presented by ascorbic acid, or sodium ascorbate, or calcium ascorbate, or palmityl ascorbate, or 4-methyl-2,6-ditertbutylphenol, or tertbutylhydroquinone, 2,4,5-trihydroxybutyrophenone, or sodium metabisulphite, or alpha tocopherol, or thioglycerol, or combinations thereof; the preserving agent is presented in the form of benzyl alcohol, parabenes, chloroethanol or combinations thereof; the solvents or co-solvents are organic solvents, including dimethylacetamide, or dimethylsulphoxide, or N-methyl-2-pyrrolidone, or 2-pyrrolidone, or combinations thereof, or combinations of organic solvents with water in the following relations, wt %: azithromycin 5-50, antioxidant 0.1-0.2, preserving agent 1-2, pH regulator up to 5, solvents the rest.
EFFECT: antibacterial injectable pharmaceutical composition of azithromycin possesses a wide spectrum of the antimicrobial action, and is applicable to the intravenous, intramuscular, subcutaneous, intrauterine and intracisternal introduction.
3 cl, 1 dwg, 7 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INCREASING THE STABILITY OF INJECTION PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2666607C1 |
INJECTION DRUG FORM FOR TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2012 |
|
RU2504347C1 |
COMPOSITION FOR TREATING BACTERIAL INFECTIONS IN ANIMALS | 2009 |
|
RU2397753C1 |
INJECTION MEDICINAL FORMULATION FOR TREATMENT AND PROPHYLAXIS OF BLOOD-PARASITIC AND INVASION DISEASES | 2005 |
|
RU2296568C1 |
INJECTABLE DOSAGE FORM FOR THE TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2021 |
|
RU2800150C2 |
HEPATOPROTECTIVE INJECTION PHARMACEUTICAL COMPOSITION ON THE BASIS OF SILIMARINE AND NANOPARTICLES OF SELENIUM | 2017 |
|
RU2645092C1 |
PHARMACEUTICAL COMPOSITION FOR HISTONE DEACETYLASE INHIBITORS | 2011 |
|
RU2625758C2 |
MICROCOLLOIDAL SOLUTION OF PROPOFOL FOR ANAESTHESIA | 2013 |
|
RU2535001C1 |
MEDICATIONS, CONTAINING FLUOROQUINOLONES | 2007 |
|
RU2527327C2 |
INJECTION MEDICINAL FORM OF METRONIDAZOLE | 2000 |
|
RU2173993C1 |
Authors
Dates
2014-04-10—Published
2012-06-08—Filed